{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-22-001222","form_type":"8-K","ticker":"TARA","cik":"0001359931","company_name":"Protara Therapeutics, Inc.","filed_at":"2022-01-10T23:59:59+00:00","discovered_at":"2026-05-14T18:04:06.108553+00:00","generated_at":"2026-06-27T19:16:48.193274+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Protara Therapeutics appoints Jathin Bandari as Chief Medical Officer","bullets":["Dr. Bandari, previously Interim CMO, appointed permanent CMO effective Jan 10, 2022.","Annual base salary of $415,000, discretionary bonus target 40% of base.","Granted stock option for 81,000 shares and RSU for 13,500 shares, subject to board approval.","Severance: 9 months salary plus target bonus and healthcare if terminated without cause or for good reason.","In change of control termination, 100% acceleration of unvested equity."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-22-001222","json":"https://secwatch.observer/filing/0001213900-22-001222.json","markdown":"https://secwatch.observer/filing/0001213900-22-001222.md","text":"https://secwatch.observer/filing/0001213900-22-001222.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1359931/000121390022001222/0001213900-22-001222-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1359931/000121390022001222/ea153715-8k_protarathera.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T19:16:48.193274+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"f7935fa6ab","claim":"Jathin Bandari was appointed as Chief Medical Officer at Protara Therapeutics, Inc..","evidence_excerpt":"Effective as of January 10, 2022 (the “Effective Date”), Protara Therapeutics, Inc. (the “Company”) appointed Jathin Bandari, M.D. as Chief Medical Officer of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390022001222/0001213900-22-001222-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Medical Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}